Systemair receives major order for Swedish hosp...
Systemair (NASDAQ OMX Stockholm: SYSR) has received an order worth approximately
SEK 60 million by Skanska Healthcare AB for the University Hospital New
Karolinska Solna, Sweden. Systemair will deliver approx 115 air handling units.
New Karolinska Solna (NKS) will be a completely new State-of-the-art teaching
hospital with the task of providing highly specialized healthcare, research and
education of excellent quality on large scale. The new hospital is scheduled to
open it's door for the first patient in 2016 and be completely ready in 2017.
The project New Karolinska Solna is operated through a Private Public
Partnership (PPP). This is the world's largest PPP-hospital and Sweden's first
PPP-building, and the first PPP-University Hospital with the ambition to become
certified under the LEED Gold (Leadership in Energy and Environmental Design).
- "We are proud to be selected to deliver all the air handling units to the New
Karolinska Solna among 73 suppliers who were surveyed", says Pär Johansson Sales
Manager Sweden.
-"Our challenge was to deliver the most energy-efficient air handling units as
possible at the right price. The focus for Skanska has been on the operating
life cycle cost. Skanska is responsible for the operation of the hospital for
20 years. Our products were deemed to be the best in both energy efficiency and
as investment", continues Pär Johansson.
- "This is our biggest order so far and it proves that our product development
is in the forefront. Systemair is meeting the high demands for energy recovery
ventilation in modern buildings", says Systemair's CEO Gerald Engström.
For further information, please contact:
Gerald Engström, CEO, +46 222 440 01, +46 70 519 00 01
Pär Johansson, Sales Manager Sweden, +46 8 55 44 26 05, +46 70 323 40 19
Systemair AB, SE-739 30 Skinnskatteberg, Sweden, +46Â 222 440 00,
www.systemair.com
Note:Â The information in this press release is information that Systemair AB is
required to disclose in accordance with the Swedish Securities Markets Act
and/or the Swedish Financial Instruments Trading Act. Swedish and English
versions of this information have been submitted for publication at 11.00 am on
2 December 2011.
Systemair in brief
Systemair is a leading ventilation company with operations in 41 countries in
Europe, North- and South America, the Middle East, Asia, Africa and Australia.
The Company had sales of SEK 3.47 billion in financial 2010/11 and currently
employs about 2,800 people. Systemair has reported an operating profit every
year since 1974, when the Company was founded. During the past 15 years, the
Company's growth rate has averaged about 15 percent.
Systemair has well-established operations in growth markets. The Group's
products are marketed under the Systemair, Frico, VEAB and Fantech brands.
Systemair shares have been quoted on the Mid Cap List of the OMX Nordic Exchange
in Stockholm since October 2007. The Group comprises about 60 companies.
Press release PDF:
http://hugin.info/138279/R/1568414/487449.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Systemair AB via Thomson Reuters ONE
[HUG#1568414]
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.